Somatostatin in Alzheimer's disease: A new Role for an Old Player

References

• Kang J, Lemaire HG, Unterbeck A, et al. The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor. Nature 1987;325(6106):733–6. doi:10.1038/325733a0.
   PubMed Web of Science ®Google Scholar
• Haass C, Selkoe DJ. Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid beta-peptide. Nat Rev Mol Cell Biol. 2007;8(2):101–12. doi:10.1038/nrm2101.
   PubMed Web of Science ®Google Scholar
• Benilova I, Karran E, De Strooper B. The toxic Abeta oligomer and Alzheimer's disease: an emperor in need of clothes. Nat Neurosci. 2012;15(3):349–57.
   PubMed Web of Science ®Google Scholar
• Narayan P, Orte A, Clarke RW, et al. The extracellular chaperone clusterin sequesters oligomeric forms of the amyloid-beta(1–40) peptide. Nat Struct Mol Biol. 2012;19(1):79–83. doi:10.1038/nsmb.2191.
   Web of Science ®Google Scholar
• Jarosz-Griffiths HH, Noble E, Rushworth JV, et al. Amyloid-beta Receptors: The Good, the Bad, and the Prion Protein. J Biol Chem. 2016;291(7):3174–83. doi:10.1074/jbc.R115.702704.
   PubMed Web of Science ®Google Scholar
• LaFerla FM, Green, KN, Oddo, S. Intracellular amyloid-beta in Alzheimer's disease. Nat Rev Neurosci. 2007;8:11. doi:10.1038/nrn2168.
   PubMed Web of Science ®Google Scholar
• Lustbader JW, Cirilli M, Lin C, et al. ABAD directly links Abeta to mitochondrial toxicity in Alzheimer's disease. Science. 2004;304(5669):448–52. doi:10.1126/science.1091230.
   PubMed Web of Science ®Google Scholar
• Wang H, Muiznieks LD, Ghosh P, et al. Somatostatin binds to the human amyloid beta peptide and favors the formation of distinct oligomers. Elife. 2017;6:e28401. doi:10.7554/eLife.28401.
   PubMed Web of Science ®Google Scholar
• van Grondelle W, Iglesias CL, Coll E, et al. Spontaneous fibrillation of the native neuropeptide hormone Somatostatin-14. J Struct Biol. 2007;160(2):211–23. doi:10.1016/j.jsb.2007.08.006.
   PubMed Web of Science ®Google Scholar
• Maji SK, Perrin MH, Sawaya MR, et al. Functional amyloids as natural storage of peptide hormones in pituitary secretory granules. Science. 2009;325(5938):328–32. doi:10.1126/science.1173155.
   PubMed Web of Science ®Google Scholar
• Hervas R, Li L, Majumdar A, et al. Molecular Basis of Orb2 Amyloidogenesis and Blockade of Memory Consolidation. PLoS Biol. 2016;14(1):e1002361. doi:10.1371/journal.pbio.1002361.
   PubMed Web of Science ®Google Scholar
• Chen SG, Stribinskis V, Rane MJ, et al. Exposure to the Functional Bacterial Amyloid Protein Curli Enhances Alpha-Synuclein Aggregation in Aged Fischer 344 Rats and Caenorhabditis elegans. Sci Rep. 2016;6:34477. doi:10.1038/srep34477.
   PubMed Web of Science ®Google Scholar
• Gremer L, Scholzel D, Schenk C, et al. Fibril structure of amyloid-ss(1–42) by cryoelectron microscopy. Science. 2017;358(6359):116–9. doi:10.1126/science.aao2825.
   PubMed Web of Science ®Google Scholar
• Sawaya MR, Sambashivan S, Nelson R, et al. Atomic structures of amyloid cross-beta spines reveal varied steric zippers. Nature. 2007;447(7143):453–7. doi:10.1038/nature05695.
   PubMed Web of Science ®Google Scholar
• Schettini G. Brain somatostatin: Receptor-coupled transducing mechanisms and role in cognitive functions. Pharmacol Res 1991;23(3):13. doi:10.1016/S1043-6618(05)80080-5.
   PubMed Web of Science ®Google Scholar
• Gahete MD, Rubio A, Duran-Prado M, et al. Expression of Somatostatin, cortistatin, and their receptors, as well as dopamine receptors, but not of neprilysin, are reduced in the temporal lobe of Alzheimer's disease patients. J Alzheimers Dis. 2010;20(2):465–75. doi:10.3233/JAD-2010-1385.
   PubMed Web of Science ®Google Scholar
• Dalm VA, Van Hagen PM, de Krijger RR, et al. Distribution pattern of somatostatin and cortistatin mRNA in human central and peripheral tissues. Clin Endocrinol (Oxf). 2004;60(5):625–9. doi:10.1111/j.1365-2265.2004.02024.x.
   PubMed Web of Science ®Google Scholar
• Cordoba-Chacon J, Gahete MD, Pozo-Salas AI, et al. Cortistatin is not a somatostatin analogue but stimulates prolactin release and inhibits GH and ACTH in a gender-dependent fashion: potential role of ghrelin. Endocrinology. 2011;152(12):4800–12. doi:10.1210/en.2011-1542.
   PubMed Web of Science ®Google Scholar
• Lu T, Pan Y, Kao SY, et al. Gene regulation and DNA damage in the ageing human brain. Nature. 2004;429(6994):883–91. doi:10.1038/nature02661.
   PubMed Web of Science ®Google Scholar
• Saiz-Sanchez D, De la Rosa-Prieto C, et al. Interneurons, tau and amyloid-beta in the piriform cortex in Alzheimer's disease. Brain Struct Funct. 2015;220(4):2011–25. doi:10.1007/s00429-014-0771-3.
   PubMed Web of Science ®Google Scholar
• Saiz-Sanchez D, Ubeda-Banon I, de la Rosa-Prieto C, et al. Somatostatin, tau, and beta-amyloid within the anterior olfactory nucleus in Alzheimer disease. Exp Neurol. 2010;223(2):347–50. doi:10.1016/j.expneurol.2009.06.010.
   PubMed Web of Science ®Google Scholar
• Davies P, Katzman R, Terry RD. Reduced somatostatin-like immunoreactivity in cerebral cortex from cases of Alzheimer disease and Alzheimer senile dementa. Nature 1980;288(5788):279–80. doi:10.1038/288279a0.
   PubMed Web of Science ®Google Scholar
• Morrison JH, Rogers J, Scherr S, et al. Somatostatin immunoreactivity in neuritic plaques of Alzheimer's patients. Nature 1985;314(6006):90–2. doi:10.1038/314090a0.
   PubMed Web of Science ®Google Scholar
• Armstrong DM, LeRoy S, Shields D, Terry RD. Somatostatin-like immunoreactivity within neuritic plaques. Brain Res 1985;338(1):71–9. doi:10.1016/0006-8993(85)90249-5.
   PubMed Web of Science ®Google Scholar
• Saito T, Iwata N, Tsubuki S, et al. Somatostatin regulates brain amyloid beta peptide Abeta42 through modulation of proteolytic degradation. Nat Med. 2005;11(4):434–9. doi:10.1038/nm1206.
   PubMed Web of Science ®Google Scholar
• Vepsalainen S, Helisalmi S, Koivisto AM, et al. Somatostatin genetic variants modify the risk for Alzheimer's disease among Finnish patients. J Neurol. 2007;254(11):1504–08. doi:10.1007/s00415-007-0539-2.
   PubMed Web of Science ®Google Scholar
• Xue S, Jia L, Jia J. Association between somatostatin gene polymorphisms and sporadic Alzheimer's disease in Chinese population. Neurosci Lett. 2009;465(2):181–3. doi:10.1016/j.neulet.2009.09.002.
   PubMed Web of Science ®Google Scholar
• Sarell CJ, Stockley PG, Radford SE. Assessing the causes and consequences of co-polymerization in amyloid formation. Prion. 2013;7(5):359–68. doi:10.4161/pri.26415.
   PubMed Web of Science ®Google Scholar
• Ono K, Takahashi R, Ikeda T, et al. Cross-seeding effects of amyloid beta-protein and alpha-synuclein. J Neurochem. 2012;122(5):883–90. doi:10.1111/j.1471-4159.2012.07847.x.
   PubMed Web of Science ®Google Scholar
• Tsigelny IF, Crews L, Desplats P, et al. Mechanisms of hybrid oligomer formation in the pathogenesis of combined Alzheimer's and Parkinson's diseases. PLoS One. 2008;3(9):e3135. doi:10.1371/journal.pone.0003135.
   PubMed Web of Science ®Google Scholar
• Morales R, Estrada LD, Diaz-Espinoza R, et al. Molecular cross talk between misfolded proteins in animal models of Alzheimer's and prion diseases. J Neurosci. 2010;30(13):4528–35. doi:10.1523/JNEUROSCI.5924-09.2010.
   PubMed Web of Science ®Google Scholar
• Soto C, Kindy MS, Baumann M, et al. Inhibition of Alzheimer's amyloidosis by peptides that prevent beta-sheet conformation. Biochem Biophys Res Commun 1996;226(3):672–80. doi:10.1006/bbrc.1996.1413.
   PubMed Web of Science ®Google Scholar
• Hama E, Saido TC. Etiology of sporadic Alzheimer's disease: somatostatin, neprilysin, and amyloid beta peptide. Med Hypotheses. 2005;65(3):498–500. doi:10.1016/j.mehy.2005.02.045.
   PubMed Web of Science ®Google Scholar
• Anoop A, Ranganathan S, Das Dhaked B, et al. Elucidating the role of disulfide bond on amyloid formation and fibril reversibility of somatostatin-14: relevance to its storage and secretion. J Biol Chem. 2014;289(24):16884–903. doi:10.1074/jbc.M114.548354.
   PubMed Web of Science ®Google Scholar
• Maji SK, Schubert D, Rivier C, et al. Amyloid as a depot for the formulation of long-acting drugs. PLoS Biol. 2008;6(2):e17. doi:10.1371/journal.pbio.0060017.
   PubMed Web of Science ®Google Scholar
• Pohl E, Heine A, Sheldrick GM, et al. Structure of octreotide, a somatostatin analogue. Acta Crystallogr D Biol Crystallogr 1995;51(Pt 1):48–59. doi:10.1107/S0907444994006104.
   PubMedGoogle Scholar
• Epelbaum J, Guillou JL, Gastambide F, et al. Somatostatin, Alzheimer's disease and cognition: an old story coming of age?. Prog Neurobiol. 2009;89(2):153–61. doi:10.1016/j.pneurobio.2009.07.002.
   PubMed Web of Science ®Google Scholar